ADVERTISING MATERIAL
Home Email This page Print Bookmark
{ Bio Image }

F. Mark Reuter

Partner

Mark Reuter advocates for business clients in transactions, proceedings and conflicts regulated by federal and state securities laws and stock exchange rules.  A partner in the firm’s Business Representation and Transactions Group, Mark has extensive experience representing publicly traded and privately owned clients in strategic transactions, executive compensation and equity arrangements, corporate governance, reporting, internal investigations, and administrative actions.  Mark regularly advises management, boards and their committees, and other stakeholders in mergers and acquisitions, public offerings, follow-on equity offerings, investment grade and convertible debt offerings, tender offers, private placements, proxy solicitations, and issues arising under the Dodd-Frank Act, the Sarbanes-Oxley Act, and state corporate law.

Mark has been recognized by Best Lawyers in America as the 2017 "Lawyer of the Year" in Securities Regulation Law in Cincinnati, Ohio.

Mark's representative transactions include:

  • American Financial Group in its: $285 million tender offer for National Interstate; underwritten offerings of senior and subordinated debt securities of $200 million, $150 million and $132 million;
  • Armstrong World Industries, Inc. Asbestos Personal Injury Settlement Trust in underwritten secondary offerings of equity securities of $450 million, $230 million, $185 million, and $100 million and related $125 million share repurchase by AWI; $150 million and $85 million block trades under Rule 144;
  • AtriCure in its: $90 million and $25 million underwritten secondary offerings of equity securities; $60 million acquisition of Endoscopic Technologies; $100 million acquisition of nContact Surgical;
  • Casablanca Capital in its proxy contest involving Cliffs Natural Resources;
  • Casey Capital in its proxy contest involving Essex Rental;
  • Cintas Corporation in its $350 million acquisition of Unitog through the issuance of equity securities in a merger proxy solicitation;
  • ERBA Diagnostics in its acquisition of the Drew Scientific businesses of Escalon Medical;
  • Escort Holdings in its acquisition by Falconhead Capital;
  • Great American Financial Resources in its: $235 million going private transaction; $125 million underwritten offerings of trust preferred securities;
  • Hemagen Diagnostics in its exchange offer for senior secured convertible debt securities;
  • Infinity Property & Casualty Corporation in its $275 million underwritten secondary offering of senior debt securities and related redemption of $210 million of senior debt securities;
  • Kendle International in its: $230 million merger with Avista/INC Research and related consent solicitation for $140 million of senior subordinated convertible debt securities; $215 million acquisition of clinical services businesses of Charles River Laboratories; $225 million underwritten offering of senior subordinated convertible debt securities and related hedging transactions; acquisition of DecisionLine Clinical Research;
  • Lenox Wealth Management in its proxy contests and unsolicited offers involving Lenox Bancorp and First Franklin Corporation;
  • LSI Industries in its $50 million underwritten secondary offering of equity securities;
  • Meridian Bioscience in $60 million underwritten secondary offering of equity securities;
  • Midland Company in its: $1.3 billion merger with Munich Re; $60 million underwritten secondary offerings of equity securities; $24 million underwritten offerings of trust preferred securities;
  • Multi-Color Corporation in its $355 million acquisition of York Label Group and related issuance of equity securities; $250 million underwritten offering of senior debt securities under Rule 144A and Regulation S;
  • Provident Financial Group in its: $2.1 billion merger with National City; $225 million underwritten offerings of trust preferred securities;
  • RX Investor Value Corp. in its proxy contest involving HealthWarehouse.com, Inc.;
  • TALP Acquisition in its $35 million acquisition of Tab Products;
  • WR Grace Asbestos PI Trust in its underwritten secondary offering of Sealed Air Corporation equity securities of $295 million and related share repurchase by Sealed Air; $335 million block trade under Rule 144;
  • A privately held trust in its sale of interests in Major League Baseball and National Football League teams.

Awards & Recognitions

  • AV® Preeminent™ Peer Review Rated, Martindale-Hubbell
  • Named by Best Lawyers in America as the 2017 "Lawyer of the Year" for Securities Regulation in Cincinnati
  • Named by Best Lawyers in America as the 2016 "Lawyer of the Year" for Securities / Capital Markets Law in Cincinnati
  • Named by Best Lawyers in America as the 2014 "Lawyer of the Year" for Securities Regulation in Cincinnati
  • Listed in The Best Lawyers in America, 2011-2017
  • Listed in Chambers USA: America's Leading Business Lawyers, 2013-2016
  • Named to Ohio Super Lawyers, 2012-2013
  • Named to Ohio Rising Stars, 2005-2011
  • Cincinnati Academy of Leadership for Lawyers, Class VII (2003), Fellow

News

Speaking Engagements

Publications

Professional & Community Involvement

  • Bannockburn Global Forex, Advisory Board
  • Cincinnati Bar Association, Ethics & Professional Responsibility Committee
  • Ohio State Bar Association, Corporation Law Committee
  • Summit Country Day School, Board of Trustees
Keating Muething & Klekamp PLL
One East Fourth Street
Suite 1400
Cincinnati OH 45202
TEL: (513) 579-6469
FAX: (513) 579-6457

{ Chambers & Partners Image }

{ Best Lawyers Image }

{ Super Lawyers Image }

{ Martindale Image }

Best Lawyers Award Badge

Practice Areas

Blog Contributions

Bar & Court Admissions
  • Ohio
Education
  • J.D., University of Notre Dame Law School, 1996; cum laude
  • B.A., University of Notre Dame, 1992; magna cum laude